Integrated Diagnostics Holdings PLC
LSE:IDHC

Watchlist Manager
Integrated Diagnostics Holdings PLC Logo
Integrated Diagnostics Holdings PLC
LSE:IDHC
Watchlist
Price: 0.335 USD -2.62% Market Closed
Market Cap: 194.7m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+180%
Revenue
Forecast
+20%
Operating Income
Forecast
+32%
Net Income
Forecast
N/A

Wall Street
Price Targets

IDHC Price Targets Summary
Integrated Diagnostics Holdings PLC

Wall Street analysts forecast IDHC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IDHC is 0.938 USD with a low forecast of 0.929 USD and a high forecast of 0.966 USD.

IDHC Lowest Forecast
Wall Street Target
0.929 USD
177% Upside
IDHC Average Forecast
Wall Street Target
0.938 USD
180% Upside
IDHC Highest Forecast
Wall Street Target
0.966 USD
188% Upside
Lowest
Price Target
0.929 USD
177% Upside
Average
Price Target
0.938 USD
180% Upside
Highest
Price Target
0.966 USD
188% Upside
Integrated Diagnostics Holdings PLC Competitors:
Price Targets
METROPOLIS
Metropolis Healthcare Ltd
1% Upside
286A
EUCALIA Inc
43% Upside
2522
Jiangxi Rimag Group Co Ltd
264% Upside
O
OPTIMAX
Optimax Holdings Bhd
60% Upside
METROPOLIS
Metropolis Healthcare Ltd
1% Upside
286A
EUCALIA Inc
43% Upside
2522
Jiangxi Rimag Group Co Ltd
264% Upside
O
OPTIMAX
Optimax Holdings Bhd
60% Upside
FLRY3
Fleury SA
13% Upside
CCRN
Cross Country Healthcare Inc
47% Upside
I
INFU
InfuSystem Holdings Inc
157% Upside
INNV
InnovAge Holding Corp
37% Upside

Revenue
Forecast

Revenue Estimate
Integrated Diagnostics Holdings PLC

For the last 11 years the compound annual growth rate for Integrated Diagnostics Holdings PLC's revenue is 21%. The projected CAGR for the next 3 years is 20%.

21%
Past Growth
20%
Estimated Growth
Estimates Accuracy
0%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Integrated Diagnostics Holdings PLC

For the last 11 years the compound annual growth rate for Integrated Diagnostics Holdings PLC's operating income is 22%. The projected CAGR for the next 3 years is 32%.

22%
Past Growth
32%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Integrated Diagnostics Holdings PLC

For the last 11 years the compound annual growth rate for Integrated Diagnostics Holdings PLC's net income is 30%. The projected CAGR for the next 2 years is 13%.

30%
Past Growth
13%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

See Also

Summary
IDHC intrinsic value, competitors valuation, and company profile.
DCF Valuation
IDHC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
IDHC stock valuation using valuation multiples.
Wall Street Estimates
IDHC price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
IDHC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IDHC's stock price target?
Price Target
0.938 USD

According to Wall Street analysts, the average 1-year price target for IDHC is 0.938 USD with a low forecast of 0.929 USD and a high forecast of 0.966 USD.

What is Integrated Diagnostics Holdings PLC's Revenue forecast?
Projected CAGR
20%

For the last 11 years the compound annual growth rate for Integrated Diagnostics Holdings PLC's revenue is 21%. The projected CAGR for the next 3 years is 20%.

What is Integrated Diagnostics Holdings PLC's Operating Income forecast?
Projected CAGR
32%

For the last 11 years the compound annual growth rate for Integrated Diagnostics Holdings PLC's operating income is 22%. The projected CAGR for the next 3 years is 32%.

What is Integrated Diagnostics Holdings PLC's Net Income forecast?
Projected CAGR
13%

For the last 11 years the compound annual growth rate for Integrated Diagnostics Holdings PLC's net income is 30%. The projected CAGR for the next 2 years is 13%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 268,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.